The global markets saw significant capital concentration between 31 January 2025 and 31 January 2026, with AI infrastructure and semiconductor companies gaining value while traditional defensive and enterprise software sectors contracted. This market pivot reflects investors re-evaluating growth durability, regulatory factors, and long-term earnings potential, reveals the Company Profiles Database of GlobalData, a leading intelligence and productivity platform.
AI supply chain captures bulk of new wealth
Nvidia delivered the largest jump of any company, adding $1.7 trillion in market value to end at $4.64 trillion. Investors continued to treat it as the clearest public-market bet on growing demand for AI computing. Alphabet was close behind, rising by $1.58 trillion to $4.08 trillion, as confidence improved that its scale across Search, YouTube, and cloud can turn AI spending into real monetization.
Murthy Grandhi, Company Profiles Analyst at GlobalData, comments: “The rest of the top gainers looked like “a map of the semiconductor stack.” TSMC (+$561 billion) and Broadcom (+$534 billion) climbed strongly, alongside Samsung Electronics (+$481 billion), Micron (+$365 billion), and SK Hynix (+$359 billion). Together, these moves support the idea that this isn’t just a software-driven AI cycle—it’s also about components, manufacturing capacity, and supply constraints. ASML (+$224 billion) rose as well, reflecting the premium investors placed on the specialized equipment needed to expand leading-edge chip production.”
Outside semiconductors, Tesla (+$314 billion) and Apple (+$266 billion) also gained, though they lagged companies positioned closer to AI’s biggest hardware bottlenecks. Healthcare stood out as a separate pocket of strength, with Eli Lilly (+$211 billion) and Johnson & Johnson (+$181 billion) among the notable winners, suggesting investors still value durable healthcare franchises.
Laggards tell a different story
The biggest decline came from UnitedHealth Group, which shed $239 billion in market value as US President Donald Trump pressed for lower costs in an increasingly unaffordable healthcare system. Sentiment weakened further after Medicare rate news and a Q4 revenue miss ($113.2 billion). UnitedHealthcare expects up to 2.8 million fewer members in 2026, with Medicare Advantage accounting for nearly half the decline. The company has been trying to recover from last year’s selloff after a sharp profit-cut forecast, followed by withdrawn guidance, the CEO’s resignation, and a Department of Justice (DOJ) probe into Medicare Advantage billing.
Energy also moved lower. Saudi Aramco dropped $129 billion, even though it remained worth $1.67 trillion. The decline suggests investors valued the sector’s cash flows less than a year earlier, reflecting long-term demand uncertainty and geopolitical headline risk.
Grandhi adds: “Enterprise software was a consistent pocket of weakness. Salesforce (-$128 billion) and SAP (-$120 billion) fell sharply, along with ServiceNow (-$87 billion) and Adobe (-$70 billion). Investors were less willing to pay peak valuations without clear near-term improvement in revenue or margins—an “AI strategy” alone wasn’t enough without measurable results.”
Luxury and consumer defensives also slipped. LVMH (-$74 billion) and Hermès (-$69 billion) declined, while Procter & Gamble (-$37 billion) ended lower. That combination suggests a year where even perceived safe havens faced pressure, either from softer discretionary demand expectations or from investors rotating toward higher-beta AI exposure.
Grandhi concludes: “2026 looks less like a one-way trade and more like a stress test. With tariff threats and a tougher geopolitical environment, investors may focus on supply-chain vulnerability and policy exposure—especially in semiconductors and global consumer franchises. If 2025 was about paying almost any price for AI-linked scarcity, 2026 may be about selectivity and resilience.”
